Details of the Drug Reposition

General Information of This Drug (ID: DMQIZSG)

• Drug Name: NRL-1 (DMQIZSG)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Epilepsy	DISBB28L	8A60-8A68	Phase 3	[1]
Acute repetitive seizure	DISZCC8H	8A67	Phase 3	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)